Evandro de Azambuja, MD, PhD, of the Institut Jules Bordet, Brussels, Belgium, discusses how data from the MONARCH study (NCT02107703) is introducing chemotherapy-free treatment for patients with triple-positive metastatic breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
